Current Liabilities: The sum of all liabilities classified as current for having maturities of less than one year.
Neurogene Inc. (NGNE) had Current Liabilities of $18.87M for the most recently reported fiscal quarter, ending 2026-03-31.
| Income Statement Financials | |
-- |
|
$-30.93M |
|
-- |
|
-- |
|
$33.35M |
|
$-33.35M |
|
$2.42M |
|
$-30.93M |
|
$-30.93M |
|
$-30.93M |
|
$-30.93M |
|
$-30.93M |
|
$-30.93M |
|
$-33.35M |
|
$-32.87M |
|
22.31M |
|
22.31M |
|
$-1.39 |
|
$-1.39 |
|
| Balance Sheet Financials | |
$246.75M |
|
$12.50M |
|
$16.39M |
|
$263.14M |
|
|
Current Liabilities |
$18.87M |
$0.00M |
|
$6.49M |
|
$25.36M |
|
$237.78M |
|
$237.78M |
|
$237.78M |
|
15.62M |
|
| Cash Flow Statement Financials | |
$-26.12M |
|
$46.24M |
|
$0.20M |
|
$104.18M |
|
$124.50M |
|
$20.32M |
|
$3.63M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
13.08 |
|
-- |
|
-- |
|
0.00 |
|
0.00 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-26.40M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-13.01% |
|
-13.01% |
|
-11.76% |
|
-13.01% |
|
$15.23 |
|
$-1.18 |
|
$-1.17 |
|